An innovative pharmaceutical company with a broad portfolio of projects for the treatment of cancer and infections.
Lund, Sweden
Joined November 2025
- Tweets7
- Following39
- Followers32
- Likes1
Exciting news!
HAMLET BioPharma has signed a Letter of Intent with a German uro-oncology partner on a potential collaboration for Alpha1H in bladder cancer. Alpha1H has FDA Fast Track and clearance for a pivotal Phase III study. 🧬🤝
Read more: spotlightstockmarket.com/sv/…
🎉Our Founder, Prof. Catharina Svanborg, is featured in @FemestMag, sharing HAMLET BioPharma's story and our journey from discovery to clinic.
Plus: new highlights on novel non-antibiotic infection therapies presented at @biozentrum Basel.
Read more: hamletbiopharma.com/?p=12770…
🗞️📊Please see Hamlet BioPharma’s Q2 Interim Report (Oct–Dec 2025).
We highlight the exciting progress we’ve made and are focused on what’s ahead:
🔗 Link to the press release: hamletbiopharma.com/q2-inter…
🚨The leading international journal Nature Microbiology has published our latest paper! 🧬
Title -
Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial.
🔗 Article link: doi.org/10.1038/s41564-026-0…
🔗Link to the press release: hamletbiopharma.com/press-re…
🔬We’re hosting a one-day symposium on novel treatments for infections & cancer!
🗓 28 Jan 2026 | 📍 Belfragesalen, BMC, Lund
Talks by international experts + panel discussions.
#ScientificSymposium #CancerResearch #InfectiousDiseases #BiomedicalResearch #NovelTherapies
🎯 Major milestone: Hamlet BioPharma receives FDA feedback supporting a pivotal study for Alpha1H, our first-in-class therapy for early-stage bladder cancer.
Read more 👉bit.ly/Alpha1H-FDA
#FDA #CancerResearch #Oncology #Biotechnology #ClinicalTrials
